Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Study Summary

This is an open, single-arm, prospective，clinical study to evaluate efficacy and safety of Auto CAR-T cell injection in the treatment of recurrent or refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Interventions

Study Locations

Facility	City	State	Country
Pediatric hematology, Hebei Medical University Fourth Hospital	Shijiazhuang	Hebei	China

Official Trial Information

View on ClinicalTrials.gov